key: cord-0922917-x50teg8u
authors: Fang, Zachary B.; Simons, Jessica P.; Judelson, Dejah R.; Arous, Edward J.; Jones, Douglas W.; Steppacher, Robert C.; Schanzer, Andres; Aiello, Francesco A.
title: Financial Implications of COVID-19 on a Tertiary Academic Vascular Surgery Practice
date: 2021-02-03
journal: J Vasc Surg
DOI: 10.1016/j.jvs.2021.01.024
sha: ab2f37562964732ea31c11cda0170f441af48b8c
doc_id: 922917
cord_uid: x50teg8u

The COVID-19 pandemic has had an unprecedented impact on the healthcare system in the United States. The redistribution of resources and suspension of elective procedures and other services has placed a financial stress across all service lines. The financial impact on the practice of vascular surgery has not yet been quantified. This study hypothesized that vascular surgery divisions have experienced losses affecting the hospital and professional side that will not be recoupable without significant productivity increases. Administrative claims data for clinical services performed by the vascular surgery division at a tertiary medical center from March-April 2019 and March-April 2020 were analyzed. These claims were separated into two categories: Hospital claims (Inpatient and Outpatient) and Professional claims (professional reimbursement for all services provided). Medicare reimbursement methodologies were utilized to assign financial value: Diagnosis-Related Group (DRG) for inpatient services, Ambulatory Payment Classification (APC) for outpatient services, and Medicare Physician Fee Schedule (MPFS) for professional reimbursement and work relative value units (wRVU). Reimbursements and productivity (wRVU) were compared between the two time periods. A financial model was created to determine the increase in future productivity over baseline required to mitigate losses incurred during the pandemic. A total of 11,317 vascular surgery claims were reviewed. Hospital reimbursement during the pandemic decreased from $4,982,114 to $2,649,521, -47% (inpatient: $3,505,775 to $2,128,133, -39%; outpatient $1,476,339 to $521,388, -65%) while professional reimbursement decreased from $933,897 to $430,967, -54% when compared to the same time period in 2019. Professional productivity as measured by wRVUs sustained a similar decline from 10478 wRVU to 5386 wRVU, -51%. Modeling sensitivity analyses demonstrated that if a vascular division were able to increase Inpatient and Outpatient revenue, above pre-pandemic levels, by 10%, 5%, or 3%, it would take 9 months, 19 months, or 31 months, respectively, for the hospital to recover pandemic-associated losses. Similarly, professional reimbursement recovery would require 11 months, 20 months, or 36 months for a similar increase in productivity. The COVID-19 pandemic has had a profound and lasting impact on the world in terms of lives lost and financial hardships. The financial impact on a vascular surgery division has resulted in losses ranging from 39% to 65% when compared to pre-pandemic period the previous year. Because complete mitigation of losses is not feasible in the short-term, alternative and novel strategies are needed to financially sustain the vascular division and hospital during a prolonged recovery period.

hospital and professional side that, without significant productivity increases, will not be 1 recoupable. determined that patient informed consent was not required. The IRB waiver was maintained 9

throughout the duration of this study. Our division consisted of 8 active vascular surgeons during 10 both the pre-pandemic and pandemic study periods. A rotating call schedule was continued from 11 the pre-pandemic to pandemic study period. Fortunately, no faculty members required quarantine 12 due to COVID exposure. All vascular surgery inpatients were included in the inpatient claims as defined by the vascular 2 surgery service line. The CMS Prospective Payment Service (PPS) was utilized to obtain the 3 national reimbursement rate for inpatient hospitalizations as assigned to each DRG. 3 Geographic 4 payment adjustments for capital and labor rates were utilized for our region, however, to make 5 this methodology more widely applicable we removed adjustments such as direct and indirect 6 medical education (DME and IME), disproportionate share hospital (DSH), and other CMS 7 programs such as Value Based Purchasing (VBP), and outlier payments which may not be 8 universally applicable to other medical institutions. This allowed us to generate values that are 9

replicable at any institution using CMS values and hospital volume. The DRG relative weight for 10 each admission was multiplied by the CMS reimbursement rate as published in their annual 11 report and this resulted in an estimated reimbursement for the service. The inpatient 12 reimbursement was based on completed and submitted claims. Physician Fee Schedule (MPFS) was used to calculate the reimbursement as well as the work 1 relative value units (wRVU) generated by each claim. 5 

Reimbursements and productivity (wRVU) were compared between the pre-pandemic (March 5 and April 2019) and pandemic (March and April 2020) time periods. Medicare reimbursement 6 rates were used for the Medical Center and professional billing, and it was assumed that all 7 claims were reimbursed in order to standardize comparisons between the study time periods. 8

Modeling sensitivity analyses were used to determine the increase in future productivity over 9 baseline required to mitigate losses incurred during the pandemic. Reimbursement levels for 10 each revenue stream in 2019 were used to define baseline productivity. The time needed to 11 "make up" the difference between pandemic and baseline reimbursement levels was then 12 calculated for various increased levels in productivity. Professional productivity (as measured by wRVUs) sustained a similar decline from 10478 16 wRVU to 5386 wRVU (-51%) (Figures 3 and 4) . Modeling sensitivity analyses demonstrated that if a vascular division were able to 19

increase Medical Center Inpatient and Outpatient revenue to above pre-pandemic levels by 10%, 20 5%, or 3%, it would take 9 months, 19 months, or 31 months, respectively, for the hospital to 21 recover pandemic-associated losses (Table 1) . Similarly, professional reimbursement recovery 22 would require 11 months, 20 months, or 36 months with a 10%, 5%, or 3% increase in 23 productivity ( Table 2 ). The top five most common inpatient procedures (as sorted by DRG) were 1 compared between the pre-pandemic and pandemic study periods (Table 3) . Similarly, the top 2 five most common outpatient claims (as sorted by APC and ICD-10) were also compared 3 between the pre-pandemic and pandemic study periods (Tables 4 and 5) . In this study we demonstrate that the coronavirus pandemic has resulted in significant 2 reduction in both the medical center and professional reimbursement for a vascular surgery 3 division. The net impact of reallocation of resources, reduction in operative volume and clinic 4 visits, and attempts to safeguard patients from further exposure resulted in a more than 50% 5 reduction in reimbursement across all avenues of vascular surgery services. At our institution, 6

COVID admissions peaked at 28% of inpatients and 125% of our ICU capacity. Further, our 7 study provides compelling evidence that the financial impact of COVID-19 will be difficult to 8

While it is impossible to completely determine the clinical, social, and psychological 11 consequences of the COVID-19 pandemic, there have been numerous attempts to understand the 12 financial impact. The reason to do so is two-fold: (1) the magnitude of the loss is important for 13 developing budgets going forward and (2) the types of losses may suggest areas of opportunity 14 for recovery. Financial market analysis has estimated that the impact on US hospitals was over 15 $200 billion as of June 2020, but this report lacked a granular assessment of the impact on an 16 individual service line. 6 It is likely that different specialties suffered different magnitudes and 17 types of losses, such that a one-size-fits-all budgeting and recovery strategy may not be optimal. 18

To our knowledge, this study is the first to both quantify the financial impact of the COVID-19 19 pandemic on an academic vascular surgery division and to project the length of time and 20 increased productivity needed to recoup those losses. The COVID-19 pandemic required re-allocation of resources and personnel as well as 1 cancellation of elective procedures and visits. This was clearly seen in the reduction of outpatient 2 services, which saw a 68% reduction in volume and 65% reduction in reimbursement. Inpatient 3 services, however, were not as heavily impacted: vascular surgery inpatient services saw a 43% 4 reduction in volume and a 39% reduction in reimbursement. This is consistent with previous data 5

showing that greater than 50% of inpatient vascular care is emergent. 7 Furthermore, it is likely 6 that these inpatients, although fewer, were sicker and required more care as evidenced by the 7 reimbursement decreasing 10% less than the volume (volume decreased by 43% while 8 reimbursement only decreased by 39%). In other words, patients may have only presented if 9

absolutely necessary due to fear of contracting coronavirus in the hospital setting, which is 10 consistent with studies showing that up to 60% of patients felt uncomfortable seeking care in 11 hospitals. 8 Although there were fewer patients, they had more advanced disease (including non-12 vascular comorbidities) and thus required more services, which in turn, generated more healthcare. It is therefore critically important that hospital systems understand the losses, and can 21 estimate how long it could take for hospital and professional revenues to "bounce back." 22

Analysis by the American Hospital Association (AHA) shows losses will continue to mount at a 23 rate of more than $20 billion per month until the end of 2020 largely due to decreased patient 1 volume and cancellation of elective procedures. 1 This would bring total losses for the US health 2 system at over 320 billion dollars: a staggering amount not including the additional costs for 3 needed items such as PPE. While the CARES Act was meant to help blunt these financial 4 constraints it falls far short of covering these losses. Our institution did receive funds from the 5 CARES act but the exact amount has not been divulged. While there is some fund exchange 6 between the Medical Center and our medical group, we are not privy to the specific details and 7 have no control over distribution. This highlights the financial obstacles in recouping the losses: 8

we most likely will not be able to increase our volume above pre-pandemic levels, assuming 9 medical institutions could facilitate such increases, and safeguards such as government aid fall 10 far short of creating a stopgap for the sustained losses. 11

There are many potential obstacles to making up these losses. First, increasing hospital 13 operative volume to above pre-pandemic levels will be very challenging for both clinicians and 14 medical centers. Opening additional operating rooms for longer times during the evening or 15 weekends incurs additional personnel-related costs such as hiring additional staff and paying a 16 higher rate for overtime. At the time of writing, an additional obstacle is reduced OR availability 17 due to mandated restrictions aimed at reducing overall hospital census. There is also the risk of 18 less tangible effects such as surgeon and staff burnout. Vascular Surgery has been reported to 19

have the longest hours of any specialty in the medical profession. 9 Therefore, a 10% increase in 20 productivity over a 9 to 11-month period (the time required to recoup losses according to our 21 models) would not be sustainable or safe, especially given the recent findings of the SVS 22

Wellness Task Force showing that 30% of vascular surgeons met criteria for burnout prior to the 23 pandemic. 10 We believe that such an attempt to recoup lost revenue would certainly exacerbate 1 this finding and be detrimental to any vascular surgeon. Second, patients who have missed or had 2 their appointments rescheduled due to the pandemic may no longer be candidates for their 3 originally intended surgical procedures. An example of this would be a patient who would have 4 originally been seen with dry gangrene but presents with wet gangrene, necessitating an 5 amputation rather than a bypass. Another possibility is that patients with claudication may decide 6 to more aggressively pursue an exercise regimen than they otherwise would have, resulting in an 7 improvement in symptoms rather than deterioration. Finally, as previously stated, patients remain 8 reluctant to visit a medical center or physician's office due to ongoing concerns for contracting 9 COVID-19. 10 11 There will almost certainly be a persistent level of COVID-19 related costs as hospital 12

systems return to what has been colloquially referred to as the "new normal." This involves 13 increased costs for personal protective equipment, testing, and procedural changes until a vaccine 14 is widely available. The long-term financial impact of these changes is yet to be seen. Taking 15 these changes and the associated costs into account, it seems likely that the modeling sensitivity 16 analyses presented here are not conservative enough. To that end, we believe that the complete 17 mitigation of losses is not feasible in the short-term. Alternative, novel strategies are needed to 18 financially sustain the vascular division and hospital, during a prolonged recovery period. One 19 strategy that our institution adopted and implemented is telehealth or telemedicine. Audio and 20 visual clinical services were rapidly expanded through government regulations both at the federal 21 and state level. 11, 12 This allowed greater than 200 clinical services to be performed remotely, 22 thereby reducing physical contact and promoting social distancing. 13 This was a logical step 23 when viewed through the lens of infection control, and insurers signaled their approval by 1 reimbursing telemedicine visits akin to in-person clinic appointments. 14 Further, most insurance 2 carriers reduced or removed copayments and deductibles for telehealth visits in order to promote 3 improved access to remote care. 15 During the study period there was redeployment of team 4 members and administrative support staff to different areas of the hospital, but there were no 5 instances of furlough or termination within our institution. One of the ways in which our division 6 activities changed was the creation of a Surgical Workforce Access Team (SWAT) which 7 provided line-placement services (arterial/dialysis/central venous access) to Covid-19 ICU. 16 8

Other novel concepts that were originally utilized for COVID but may assist with increasing 9 volume could be Hospitals without Walls or temporary expansion sites. While their overall cost 10 structures and reimbursement models remain uncertain, they may serve as an adjunct resource to 11 increase volume or divert care to a lower cost venue. 17 To further reduce cost of care and 12 increase capacity, medical centers and physician groups may try to utilize lower cost sites of 13 service such as office-based labs and ambulatory surgical centers as opposed to medical centers 14 but these ventures require considerable time and resources to launch. This strategy is thus 15 unlikely to relieve short-term financial needs. Inevitably, significant government support may be 16 required either through increased reimbursements for medical services or in the forms of low 17 interest/forgivable loans or grants to help the healthcare system recoup losses. Unfortunately, the 18 current political climate does not seem to be conducive to meaningful and coordinated support 19 from the federal government. 18 

There are several limitations to our study. Our data collection period was limited to without a clear timeline for return to normalcy. This likely has the effect of decreasing the 1 magnitude of the financial loss, as decreased clinical volumes persisted into the early summer of 2 2020. The calculated values for "reimbursement per DRG" are also slightly lower than the true 3 values -this is because several adjustments, such as those for Direct and Indirect Medical 4

Education, were removed to make the calculations generalizable to non-academic medical 5 centers. Another limitation is that our reimbursement values are based on Medicare 6 reimbursement levels and do not take into account other payers. This could lead to 7 underestimation of reimbursements, though this would be somewhat offset by claims that were 8 not successfully reimbursed. We also did not incorporate the impact on office-based practices 9

(private physician offices and OBLs) or ambulatory surgical centers (ASC) as this makes up a 10 minority of the vascular surgery volume at our academic medical center. However, other reports 11 have demonstrated that more than 97% of these practices were negatively impacted with some 12 being unable to reopen. 19 While this study examined a large number of claims, due to the de-13 identified nature of the data we are not able to determine how many of the claims are unique 14 patients versus readmissions. Lastly, our division was able to adopt and implement telehealth 15 visits very early in the pandemic period, which initially constituted approximately 4% of the 16 clinical volume for the division during the study period but has markedly increased over the 1 The COVID-19 pandemic has had a devastating, profound, and lasting impact on the 2 world in terms of lives lost and financial hardships. This study details the financial impact on a 3 vascular surgery division that has resulted in losses ranging from 39% to 65% when compared to 4 the same period during the previous year. Given that the pandemic is still ongoing and that our 5 models indicate that complete mitigation of losses is not feasible in the short-term, alternative, 6 novel strategies are needed to financially sustain the vascular division and hospital, during a 7 prolonged recovery period. 254 10 269 6 *DRG codes: 38: extracranial procedures with complication or comorbidity, 39: extracranial procedures without complication or comorbidity/major complication or comorbidity, 240: amputation for circulatory system disorders except upper limb and toe with complication or comorbidity, 252: other vascular procedures with major complication or comorbidity, 253: other vascular procedures with complication or comorbidity, 254: other vascular procedures without complication or comorbidity/major complication or comorbidity, 269: aortic and heart assist procedures except pulsation balloon without complication or comorbidity/major complication or comorbidity Table 3 . Top 5 most common DRG codes during each study period *DRG codes: 38: extracranial procedures with complication or comorbidity, 39: extracranial procedures without complication or comorbidity/major complication or comorbidity, 240: amputation for circulatory system disorders except upper limb and toe with complication or comorbidity, 252: other vascular procedures with major complication or comorbidity, 253: other vascular procedures with complication or comorbidity, 254: other vascular procedures without complication or comorbidity/major complication or comorbidity, 269: aortic and heart assist procedures except pulsation balloon without complication or comorbidity/major complication or comorbidity 

American Hospital Association. New AHA Report Finds Losses Deepen for Hospitals

Health Systems Due to COVID-19. Online: American Hospital Association

The CARES Act Provides Assistance for State, Local, and Tribal Governements

2020 Final Rule and Correction Notice Tables. Centers for Medicare and Medicaid

Payment/AcuteInpatientPPS/FY2020-IPPS-Final-Rule-Home-Page-Items/FY2020-IPPS-Final

Hospital Outpatient Prospective Payment System

The coronavirus is devastating U.S. hospitals, which will lose $200 billion in revenue by the 16 end of

Defining the 20 burden, scope, and future of vascular acute care surgery

Annual Work Hours Across Physician Specialties

Burnout Among Vascular Surgeons -A Report From the SVS Wellness Committee. BIBA

Online: Department of Health and 7 Human Services

Order Expanding Access to Telehealth Services and to Protect Health

Online: Commonwealth of Massachusetts

List of Telehealth Services. 4/30/2020 ed. Online: Centers for Medicare and Medicaid 11 Services

Is Telemedicine Here to Stay? The New York Times

Some Insurers End Pandemic Waivers of Fees and Deductibles for Telehealth

Development of a surgical 16 workforce access team in the battle against COVID-19

Hospitals: CMS Flexibilities to Fight COVID-19. Online: Centers for Medicare and

As the virus consumes the U.S. government's elite, Trump presides 21 over a capital in chaos